Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Nao, Morii"'
Publikováno v:
Core Evidence. 14:51-70
Human epidermal growth factor receptor 2 (HER2)-positive breast cancer is a distinct subset of breast cancer that results from overexpression of HER2 protein. Pertuzumab-a recombinant humanized monoclonal antibody that binds to the extracellular dime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bd979df973632005cfbffa2919e1265
https://doi.org/10.2147/ce.s217848
https://doi.org/10.2147/ce.s217848
Autor:
TAKAYOSHI KIBA1,2 takkiba@hotmail.com, NAO MORII3, HIROTOSHI TAKAHASHI3, SHINJI OZAKI3, MISAO ATSUMI4, FUMI MASUMOTO4, HIROYASU YAMASHIRO3,5
Publikováno v:
Oncology Letters. May2016, Vol. 11 Issue 5, p3064-3070. 7p.
Autor:
Shinji Ozaki, Hiroyasu Yamashiro, Hirotoshi Takahashi, Fumi Masumoto, Nao Morii, Misao Atsumi, Takayoshi Kiba
Publikováno v:
Oncology Letters. 11:3064-3070
While tumor size, the presence of inflammatory carcinoma and lymph node involvement are the main prognostic factors of women with locally advanced breast cancer, the prognostic value of the estrogen receptor, progesterone receptor and human epidermal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0fedb0fa8f8f4f1955c75221fcaf07b
https://doi.org/10.3892/ol.2016.4334
https://doi.org/10.3892/ol.2016.4334
Autor:
TAKAYOSHI KIBA1 takkiba@hotmail.com, NAO MORII2,3, HIROTOSHI TAKAHASHI2, SHINJI OZAKI2, MISAO ATSUMI4, FUMI MASUMOTO4, YOSHIMI SHITAKUBO1, HIROYASU YAMASHIRO2,3
Publikováno v:
Molecular & Clinical Oncology. Jan2016, Vol. 4 Issue 1, p47-50. 4p.
We examined the expression of ER, HER2, Ki-67, CK5/6 and EGFR by immunohistochemistry in breast tumors from patients who underwent neoadjuvant chemotherapy (NAC). 88 breast cancer patients who received NAC and surgery at our institute between January
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fce9514cd3ef3007b52579f0c8993c27
https://doi.org/10.2174/9781681080239117010006
https://doi.org/10.2174/9781681080239117010006
Immunohistochemical (IHC) and molecular findings with their histopathological diagnosis are critical in the current therapeutic strategy for a breast cancer patient. These findings require considerable manual human involvement and interpretations can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e67c22cb7f2f6b9ee7a82e0254d5e13c
https://doi.org/10.2174/9781681080239117010007
https://doi.org/10.2174/9781681080239117010007
Autor:
Naoko Yasumura, Akihisa Saito, Hiroyasu Yamashiro, Tamaki Toda, Junichi Sakane, Kiyomi Taniyama, Mikie Shitaune, Yoko Kodama, Miho Tanaka, Kazuya Kuraoka, Yukari Nakagawa, Hirotoshi Takahashi, Nao Morii, Toshinao Nishimura
Publikováno v:
Journal of Analytical Oncology. 3:88-93
Ki-67 index is one of important markers that is correlated with chemotherapy response and prognosis of breast cancer patients. However, Ki-67 index is not easily provided and are limited by intra-observer error and potentially subjective decision mak
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5dde6f37d62b702e1ead4673d54fc9bc
https://doi.org/10.6000/1927-7229.2014.03.02.3
https://doi.org/10.6000/1927-7229.2014.03.02.3
Autor:
Takayoshi Kiba, Misao Atsumi, Nao Morii, Shinji Ozaki, Hiroyasu Yamashiro, Hirotoshi Takahashi, Fumi Masumoto
Publikováno v:
Breast Cancer : Targets and Therapy
Takayoshi Kiba,1 Nao Morii,2,3 Hirotoshi Takahashi,2 Shinji Ozaki,2 Misao Atsumi,4 Fumi Masumoto,4 Hiroyasu Yamashiro,2,31Division of Modern Medical Technology, Institute for Clinical Research, 2Department of Breast Surgery, National Hospital Organiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::772751d218a7c1059ac0880578f814d2
https://www.dovepress.com/pathological-response-rate-in-hormone-positive-breast-cancer-patients--peer-reviewed-article-BCTT
https://www.dovepress.com/pathological-response-rate-in-hormone-positive-breast-cancer-patients--peer-reviewed-article-BCTT
Autor:
Satoshi, Nagashima, Takayoshi, Kiba, Yoshikazu, Ogawa, Takuya, Mura, Sayoko, Kajiume, Yuuko, Okada, Nao, Morii, Hirotoshi, Takahashi, Yasunori, Ichiba, Hiroyasu, Yamashiro
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 42(5)
Here, we report about a 60-year-old woman with metastatic breast cancer who was successfully treated for paclitaxelinduced peripheral neuropathy with duloxetine. She was administered trastuzumab plus paclitaxel(PTX)combination therapy that was ultima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f8dfd48a2cbd17dd7f199ffaaafd2f4b
https://pubmed.ncbi.nlm.nih.gov/25981658
https://pubmed.ncbi.nlm.nih.gov/25981658
Autor:
Hiroyasu Yamashiro, Shinji Ozaki, Nao Morii, Takayoshi Kiba, Yoshimi Shitakubo, Misao Atsumi, Hirotoshi Takahashi, Fumi Masumoto
Publikováno v:
Molecular and clinical oncology. 4(1)
There are limited studies reported that describe the efficacy of eribulin and trastuzumab in the treatment of recurrent breast cancer. The present study examined the therapeutic efficacy of eribulin and trastuzumab in the treatment of recurrent breas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58e999fbdaa54fc954e045f2307fc95f
https://pubmed.ncbi.nlm.nih.gov/26870356
https://pubmed.ncbi.nlm.nih.gov/26870356